-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...
More »SEARCH RESULT
Patent war over drugs goes chronic -Rupali Mukherjee
-The Times of India MUMBAI: Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. Triggering a full-blown patent fight with US-based Merck, domestic generic company Glenmark has launched a more affordable version of the multinational's blockbuster...
More »‘Herbal medicines causing kidney failure, bladder cancer in India’ -Kounteya Sinha
-The Times of India LONDON: Herbal medicines are causing millions in India to develop kidney failure and bladder cancer. In a warning that is bound to cause a fresh row over the quality of Asian herbal medicines, British scientists were due to announce on Tuesday that millions of people in Asia — specially in India and China — might be exposed to the risk of kidney failure and bladder cancer from taking...
More »Patients win over patents-Srividhya Ragavan
-The Hindu Justice Prabha Sridevan’s judgment permitting the production and sale of a generic version of a cancer drug is a victory for patients. It posits the public interest, especially in matters of health care, right at the heart of intellectual property rights in India Monday was a remarkable day for Cancer patients in India. To them, the country said — “we care.” I am talking about the astounding decision by Justice...
More »'436 killed in clinical trials last year'-Durgesh Nandan Jha
-The Times of India As many as 436 people died last year due to serious adverse events (SAE) during clinical trials. Investigations are now on to ascertain how many of the deaths were caused by drugs administered to the trial subjects. Union health minister Ghulam Nabi Azad said on Friday that deaths could be due to life-threatening diseases such as cancer, heart failure and stroke or side-effects of the drugs or their...
More »